Skip to main content

Articles

Renal-Cell Carcinoma, Conference Highlights ASCO, Oncology
Adjuvant Pembrolizumab Therapy Significantly Extends Disease-Free Survival in Patients with Clear-Cell Renal-Cell Carcinoma
Phoebe Starr
Read More
FDA Approvals
Opdivo First FDA-Approved Immunotherapy for First-Line Treatment of Advanced Gastric Cancer
Read More
FDA Approvals
Keytruda Received FDA Approval for First-Line Treatment of HER2-Positive Advanced Gastric Cancer
Read More
FDA Approvals
Trodelvy Receives New Indication for Advanced Urothelial Cancer
Read More
FDA Approvals
Sarclisa Receives New Indication for Relapsed or Refractory Multiple Myeloma
Read More
FDA Approvals
FDA Alert: Pepaxto (Melphalan Flufenamide) Associated with Increased Risk of Death in Postmarketing Clinical Trial
Read More
Practice Management
Global Issues Driving US Healthcare Trends in 2021 and 2022
F. Randy Vogenberg, PhD; John Santilli, MBA
Read More
Perspectives
Concerns Related to Benefits and Harms of Real-World Shared Decision-Making for Lung Cancer Screening
James L. Mulshine, MD; David F. Yankelevitz, MD; Bruce Pyenson, FSA, MAAA
Read More
Perspectives
Thinking About 2030
David B. Nash, MD, MBA
Read More
Original Research, Pain
Insights from Real-World Analysis of Treatment Patterns in Patients with Newly Diagnosed Knee Osteoarthritis
Stan Dysart, MD, MBA; Karina Utkina, PharmD; Laura Stong, PhD; Winnie Nelson, PharmD, MS, MBA; Naomi Sacks, PhD; Bridget Healey, MPH; Faizan Niazi, PharmD
Read More
Page 22 of 244
Results 211 - 220 of 2440